Addition of a H2 Receptor Antagonist to PPI Improves Acid Control and Decreases Nocturnal Acid Breakthrough
Authors:
- Radu TutuianRTRadu Tutuian
- Donald O. CastellDCDonald O. Castell
- 1 July 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 42 (6) , 676-679
Abstract
The addition of a bedtime H2 receptor antagonist (H2RA) to proton pump inhibitor (PPI) b.i.d. to inhibit nocturnal acid breakthrough (NAB) is controversial. H2RA tolerance has been documented suggesting limitations in its long-term effect. To compare the intragastric pH and NAB occurring with twice daily PPI with or without the addition of a H2RA. Multichannel intraluminal impedance-pH studies in 100 patients were reviewed. Fifty-eight patients (female 41; mean age, 54 y; range, 17 to 85) were studied on twice daily PPI. Forty-two patients (female 36; mean age, 53 y; range 20 to 85) were studied on a PPI b.i.d.+H2RA for at least 1 month at bedtime. The percentage time of intragastric pH<4 (upright, recumbent, and total) and NAB were compared between the groups. In the patients with PPI b.i.d. 64% had NAB, compared with only 17% of patients on PPI b.i.d. and H2RA q.h.s. (P<0.001). The percent time intragastric pH<4 for patients on PPI b.i.d. was significantly higher (P<0.01) compared with patients on PPI b.i.d.+H2RA q.h.s. during upright (29.1±3.0 vs. 18.3±2.9), recumbent (33.5±3.4 vs. 12.5±3.1), and entire period (31.5±2.8 vs. 18.0±3.0). The addition of a bedtime H2RA reduces the percentage time of the intragastric pH<4 and also NAB. H2RA should be considered as adjunct therapy in whom greater suppression of gastric acid control is considered desirable.Keywords
This publication has 15 references indexed in Scilit:
- Review article: prevalence and epidemiology of gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 2004
- Review article: impact of night‐time reflux on lifestyle − unrecognized issues in reflux diseaseAlimentary Pharmacology & Therapeutics, 2004
- Profile of GERD in the Adult Population of a North East Urban CommunityJournal of Clinical Gastroenterology, 2004
- Twenty-Four Hour Ambulatory Simultaneous Impedance and pH Monitoring: A Multicenter Report of Normal Values From 60 Healthy VolunteersAmerican Journal of Gastroenterology, 2004
- Multichannel Intraluminal Impedance in Esophageal Function Testing and Gastroesophageal Reflux MonitoringJournal of Clinical Gastroenterology, 2003
- Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitorsAlimentary Pharmacology & Therapeutics, 2001
- Esophageal function testing using multichannel intraluminal impedanceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2001
- Nocturnal Recovery of Gastric Acid Secretion With Twice-Daily Dosing of Proton Pump InhibitorsAmerican Journal of Gastroenterology, 1998
- Epidemiology of gastro‐esophageal reflux diseaseWorld Journal of Surgery, 1992
- Appropriate Acid Suppression for the Management of Gastro-Oesophageal Reflux DiseaseDigestion, 1992